Medicare Enrolled

Dr. Bilal Choudry, M.D.

Epilepsy Physician · Carlsbad, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
6010 HIDDEN VALLEY RD STE 200, Carlsbad, CA 92011
7606313000
In practice since 2008 (18 years)
NPI: 1396921144 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Choudry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Choudry? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Choudry

Dr. Bilal Choudry is an epilepsy physician in Carlsbad, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Choudry performed 31,610 Medicare services across 693 unique beneficiaries.

Between the years covered by Open Payments, Dr. Choudry received a total of $275,963 from 70 pharmaceutical and/or device companies across 2057 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in epilepsy physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Choudry is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 5% volume in CA $275,963 industry payments

Medicare Practice Summary

Medicare Utilization ↗
31,610
Medicare services
Top 5% in CA for epilepsy physician
693
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,756 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
30,800 $5 $12
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
248 $101 $267
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
154 $127 $350
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
89 $52 $189
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
89 $143 $374
EEG monitoring, 12-26 hours
This procedure involves monitoring brain wave activity using an electroencephalogram (EEG) for a duration of 12 to 26 hours.
48 $253 $594
New patient office visit, complex (60-74 min) 43 $172 $455
Electronic analysis of implanted neurostimulator
Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device.
35 $12 $91
EEG monitoring, 12-26 hours with review
This procedure involves monitoring brain wave activity for 12 to 26 hours. A healthcare professional reviews the data and provides a report.
31 $131 $320
Continuous EEG brain wave monitoring
A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously.
30 $232 $450
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
25 $408 $1,003
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
18 $352 $853
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$275,963
Total received (2018-2024)
Avg $39,423/year across 7 years
Top 0% in CA for epilepsy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
2,057
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$248,666 (90.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,092 (5.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$11,205 (4.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$65,056
2023
$42,232
2022
$27,104
2021
$28,614
2020
$34,478
2019
$19,358
2018
$59,121

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$27,072
UCB, Inc.
$26,433
JAZZ PHARMACEUTICALS INC.
$7,275
LivaNova USA, Inc.
$1,692
SK Life Science, Inc.
$973
PFIZER INC.
$325
Neurelis, Inc.
$265
Teva Pharmaceuticals USA, Inc.
$210
ACADIA Pharmaceuticals Inc
$190
Lundbeck LLC
$141
Takeda Pharmaceuticals U.S.A., Inc.
$99
Neurocrine Biosciences, Inc.
$78
Lilly USA, LLC
$62
Eisai Inc.
$54
MDD US Operations, LLC
$51
CATALYST PHARMACEUTICALS, INC.
$49
NEUROPACE, INC.
$34
Sumitomo Pharma America, Inc.
$21
Alnylam Pharmaceuticals Inc.
$18
Amneal Pharmaceuticals LLC
$13
Top 3 companies account for 93.4% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$76,428
SK Life Science, Inc.
$34,705
ABBVIE INC.
$34,493
Sunovion Pharmaceuticals Inc.
$31,142
JAZZ PHARMACEUTICALS INC.
$23,194
AbbVie Inc.
$20,685
LivaNova USA, Inc.
$18,750
AQUESTIVE THERAPEUTICS, INC.
$7,320
EISAI INC.
$5,278
Eisai Inc.
$4,697
UCB SA
$4,511
Allergan, Inc.
$2,627
NEUROPACE, INC.
$1,268
Teva Pharmaceuticals USA, Inc.
$1,186
PFIZER INC.
$913
Novartis Pharmaceuticals Corporation
$818
Amgen Inc.
$815
Lilly USA, LLC
$772
Neurelis, Inc.
$602
Biohaven Pharmaceutical Holding Company Ltd.
$455
Lundbeck LLC
$432
Avanir Pharmaceuticals, Inc.
$409
Biohaven Pharmaceuticals, Inc.
$405
Sumitomo Pharma America, Inc.
$390
Greenwich Biosciences, Inc.
$376
ACADIA Pharmaceuticals Inc
$349
IMPEL PHARMACEUTICALS INC.
$232
Neurocrine Biosciences, Inc.
$219
UPSHER-SMITH LABORATORIES LLC
$203
Biogen, Inc.
$150
GENZYME CORPORATION
$132
Allergan Inc.
$124
Amneal Pharmaceuticals LLC
$122
Merz North America, Inc.
$116
Promius Pharma LLC
$114
Merz Pharmaceuticals, LLC
$101
Takeda Pharmaceuticals U.S.A., Inc.
$99
MDD US Operations, LLC
$90
Upsher-Smith Laboratories LLC
$86
Supernus Pharmaceuticals, Inc.
$85
Boston Scientific Corporation
$81
Kyowa Kirin, Inc.
$80
Assertio Therapeutics, Inc.
$79
CSL Behring
$72
Adamas Pharmaceuticals, Inc.
$66
US WorldMeds, LLC
$62
Acorda Therapeutics, Inc
$56
CATALYST PHARMACEUTICALS, INC.
$49
Alexion Pharmaceuticals, Inc.
$46
ARBOR PHARMACEUTICALS, INC.
$46
Alnylam Pharmaceuticals Inc.
$39
Bausch Health US, LLC
$37
EMD Serono, Inc.
$33
Ipsen Biopharmaceuticals, Inc
$32
Medtronic, Inc.
$28
Ceribell, Inc.
$24
Catalyst Pharmaceuticals, Inc.
$23
Grifols USA, LLC
$22
Scilex Pharmaceuticals Inc.
$21
Marinus Pharmaceuticals, Inc.
$21
Medtronic USA, Inc.
$17
Aprecia Pharmaceuticals, LLC
$16
Mallinckrodt Enterprises LLC
$15
Neuronetics, Inc.
$15
Abbott Laboratories
$15
PORTOLA PHARMACEUTICALS, INC.
$15
Itamar Medical Inc
$15
Xeris Pharmaceuticals, Inc.
$14
Arbor Pharmaceuticals, Inc.
$14
Zyla Life Sciences, Inc.
$13
Top 3 companies account for 52.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Banzel · Briviact · CAMBIA · COMIRNATY · COPAXONE · Cenobamate · Ceribell Rapid Response EEG · DAYBUE · DUOPA · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · FYCOMPA · Fintepla · Fycompa · GENERAL PAIN MANAGEMENT · GILENYA · GIVLAARI · GOCOVRI · Gocovri · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LUMIZYME · Leqembi · MAYZENT · MIGRANAL · NEUROSTAR TMS THERAPY · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nuedexta · ONFI · ONGENTYS · ONZETRA Xsail · OXTELLAR XR · Ongentys · PAXLOVID · PERCEPT PC BRAINSENSE · POMPE - DISEASE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · REYVOW · RNS Neurostimulator Kit · RNS System · RYTARY · Rystiggo · SOLIRIS · SPRIX · SYMPAZAN · Spritam · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · VALTOCO · VERCISE · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VYALEV · VYEPTI · Vimpat · WatchPAT · XCOPRI · XEOMIN · Xembify · Xeomin · ZAVZPRET · ZEMBRACE SYMTOUCH · ZOMIG · ZTALMY · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in epilepsy physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for epilepsy physician in CA.

Looking for an epilepsy physician in Carlsbad?
Compare epilepsy physicians in the Carlsbad area by procedure volume, costs, and industry payment transparency.
Browse epilepsy physicians nearby

Geographic Context

Epilepsy physicians within 10 mi
3
Per 100K population
0.1
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL - ENCINITAS
4.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Choudry is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with speaking/promotional industry engagement in the top 0% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Choudry experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Choudry performed 30,800 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Choudry receive payments from pharmaceutical companies?
Yes. Dr. Choudry received a total of $275,963 from 70 companies across 2,057 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Choudry's costs compare to other epilepsy physicians in Carlsbad?
Dr. Choudry's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Choudry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →